The spinal cord injury therapeutics sector is expanding rapidly, fueled by rising trauma cases and advancements in regenerative medicine. Emerging therapies like stem cell treatments and neuroprotection **** are transforming care paradigms. Major players including Lineage Cell Therapeutics, ReNetX Bio, and NervGen Pharma are driving innovation through clinical-stage programs targeting neural repair and functional recovery.
View Complete Market Report:
https://www.delveinsight.com/i....nfographics/spinal-c
Comment
Share
